Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Robertsonian translocation can cause recurrent miscarriages.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Childhood cancer diagnosis leads to long-term physical and emotional health issues in parents.

Unhealthy diets are linked to higher BMI in young women with PCOS.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Most medical students in North India know about PCOS and how lifestyle changes can affect it; early screening is important to prevent complications.

Women with different PCOS types have similar fertility treatment results.

Reduced neurosteroids and growth issues can harm fetal brain development, especially in males.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Hormone levels change during puberty, leading to physical developments like pubic hair and voice changes.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Insulin resistance and hyperinsulinism are linked to fertility issues and can worsen symptoms of PCOS.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Metformin and clomiphene citrate together improve pregnancy chances and reduce miscarriages in women with PCOS.

Environmental and social factors greatly affect women's reproductive health.

The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.